Pharmabiz56m
UK MHRA grants marketing approval to Lilly's Kisunla to treat mild cognitive impairment and mild dementia due to Alzheimer's disease
UK MHRA grants marketing approval to Lilly's Kisunla to treat mild cognitive impairment and mild dementia due to Alzheimer's disease: Indianapolis Thursday, October 24, 2024, 09:0 ...
Pharmabiz1h
Indian clinical research companies go hitech to streamline patient recruitment & predict accurate outcomes
Indian clinical research companies go hitech to streamline patient recruitment & predict accurate outcomes: Nandita Vijayasimha, Bengaluru Thursday, October 24, 2024, 08:00 Hrs [I ...
Pharmabiz1h
FIHAV 40th Edition to offer key opportunities for Indian pharma companies
FIHAV 40th Edition to offer key opportunities for Indian pharma companies: Our Bureau, Mumbai Thursday, October 24, 2024, 08:00 Hrs [IST] The 40th Edition of the International Tra ...
Pharmabiz1h
Telangana DCA sleuths seize diverted ESI Hospital drugs from medical shops
Telangana DCA sleuths seize diverted ESI Hospital drugs from medical shops: Peethaambaran Kunnathoor, Chennai Thursday, October 24, 2024, 08:00 Hrs [IST] The drug control departme ...
Pharmabiz1h
DoP rejects review applications from five companies on pricing of modified release metoprolol
DoP rejects review applications from five companies on pricing of modified release metoprolol: Gireesh Babu, New Delhi Thursday, October 24, 2024, 08:00 Hrs [IST] The Department o ...
Pharmabiz20h
Modern HR technology reshaping workforce management for healthcare providers: Srinivas Bhararthy
The healthcare industry stands apart in its complexity and stakes—where every decision, every action can be a matter of life ...
Pharmabiz17h
OC Academy survey indicates 93.58% of Indian doctors demand specialized upskilling beyond CME
OC Academy survey indicates 93.58% of Indian doctors demand specialized upskilling beyond CME: Our Bureau, Bengaluru Wednesday, October 23, 2024, 16:40 Hrs [IST] OC Academy has in ...
Pharmabiz16h
Syngene in Q2 reports revenue from operations increased sequentially by 13% to Rs. 891 crore, down 2% year-on-year
Syngene International in its second quarter has reported revenue from operations increased sequentially by 13% but down 2% year-on-year to Rs. 891 crore compared to the corresponding quarter where it ...
Pharmabiz20h
Nucleus RadioPharma expands radiopharmaceutical research, development and manufacturing capacity
Nucleus RadioPharma expands radiopharmaceutical research, development and manufacturing capacity: Rochester, Minnesota Wednesday, October 23, 2024, 13:00 Hrs [IST] Nucleus RadioPh ...
Pharmabiz23h
US FDA clears HELP Therapeutics’ IND application for universal iPSC-derived HiCM-188 cell therapy to treat end-stage heart failure
US FDA clears HELP Therapeutics’ IND application for universal iPSC-derived HiCM-188 cell therapy to treat end-stage heart failure: Nanjing, China Wednesday, October 23, 2024, 1 ...
Pharmabiz15h
BioVersys joins EU-funded RespiriNTM Programme to accelerate development of its broad-spectrum drug candidates against NTM pulmonary diseases
BioVersys joins EU-funded RespiriNTM Programme to accelerate development of its broad-spectrum drug candidates against NTM pulmonary diseases: Basel, Switzerland Wednesday, Octobe ...
Pharmabiz17h
Asahi Kasei Medical launches Planova FG1 next-generation virus removal filter
Asahi Kasei Medical launches Planova FG1 next-generation virus removal filter: Düsseldorf, Tokyo Wednesday, October 23, 2024, 16:00 Hrs [IST] Asahi Kasei Medical has launched the ...